Ömer Sağer

3.6k citations

109 papers · 2.6k indexed · h-index 34

Genetics top 1%
- Glioma Diagnosis and Treatment 30
Otorhinolaryngology top 1%
Radiation top 2%
- Advanced Radiotherapy Techniques 24
Neurology top 2%
- Vascular Malformations Diagnosis and Treatment 12
Pulmonary and Respiratory Medicine top 2%
- Brain Metastases and Treatment 23
- Lung Cancer Diagnosis and Treatment 11
Epidemiology
- Meningioma and schwannoma management 22
Radiology, Nuclear Medicine and Imaging
- Medical Imaging Techniques and Applications 8
Cancer Research
- Breast Cancer Treatment Studies 8

Co-authors: Murat Beyzadeoğlu Ferrat Dinçoğlan Selçuk Demiral Bahar Dırıcan Hakan Gamsız Bora Uysal Kaan Oysul Sait Şirin
Cited by: Genetics Otorhinolaryngology Radiation
Journals: World Journal of Clinical Oncology (2 papers)Tumori Journal (11 papers)Electroencephalography and Clinical Neurophysiology (1 paper)
Partner nations: Türkiye Antigua and Barbuda Somalia

In The Last Decade

Ömer Sağer

104 papers receiving 2.5k citations

Peers

Countries citing papers authored by Ömer Sağer

Since Specialization

Citations

This map shows the geographic impact of Ömer Sağer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömer Sağer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömer Sağer more than expected).

Fields of papers citing papers by Ömer Sağer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ömer Sağer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömer Sağer. The network helps show where Ömer Sağer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ömer Sağer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ömer Sağer Line = papers co-authored together Ömer Sağer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	"Evaluation of Volumetric Changes in Transglottic Laryngeal Cancers After Induction Chemotherapy" Biomedical Journal of Scientific & Technical Research ·Ömer Sağer	2023	3
2	Target Definitionoforbital Embryonal Rhabdomyosarcoma (Rms) by Multimodality Imaging: An Original Article Ömer Sağer,Selçuk Demiral,Murat Beyzadeoğlu,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2021	6
3	Multimodality Imaging Based Target Definition of Cervical Lymph Nodes in Precise Limited Field Radiation Therapy (Lfrt) for Nodular Lymphocyte Predominant Hodgkin Lymphoma (Nlphl) Selçuk Demiral,Ferrat Dinçoğlan,Ömer Sağer,Murat Beyzadeoğlu,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2021	24
4	Multimodality Imaging Based Treatment Volume Definition for Reirradiation of Recurrent Small Cell Lung Cancer (SCLC) Zenodo (CERN European Organization for Nuclear Research) ·Ömer Sağer,Selçuk Demiral,Ferrat Dinçoğlan,Murat Beyzadeoğlu	2021	15
5	Assessment of Treatment Volume Definition for Irradiation of Spinal Ependymomas: an Original Article Ferrat Dinçoğlan,Murat Beyzadeoğlu,Selçuk Demiral,Ömer Sağer,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2020	31
6	Evaluation of Target Volume Determination for Irradiation of Pilocytic Astrocytomas: An Original Article Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Murat Beyzadeoğlu,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2020	6
7	8 Gy single dose radiotherapy for bone metastasis in COVID-19 pandemia period: Review Bora Uysal,Hakan Gamsız,Ferrat Dinçoğlan,Ömer Sağer,Selçuk Demiral,Murat Beyzadeoğlu	2020	0
8	Radiation Therapy (RT) for Diffuse Intrinsic Pontine Glioma (DIPG) in Children Zenodo (CERN European Organization for Nuclear Research) ·Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Bora Uysal,Ronald Prieto,Faruk Özcan,Esin Gündem,Yelda Elcim,Herbert Ward Day,Verónica Noema,Bahar Dırıcan,Murat Beyzadeoğlu	2018	3
9	Splenic Irradiation: A Concise Review of the Literature Journal of Applied Hematology ·Ömer Sağer	2017	39
10	Evaluation of linear accelerator-based stereotactic radiosurgery in the management of glomus jugulare tumors. PubMed ·Ömer Sağer,Murat Beyzadeoğlu,Ferrat Dinçoğlan,Hakan Gamsız,Selçuk Demiral,Bora Uysal,Kaan Oysul,Bahar Dırıcan,Sait Şirin	2014	25
11	Management of pulmonary oligometastases by stereotactic body radiotherapy. PubMed ·Hakan Gamsız,Murat Beyzadeoğlu,Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Bora Uysal,Serdar Sürenkök,Kaan Oysul,Bahar Dırıcan	2014	19
12	Role of radiotherapy in the management of heel spur European Journal of Orthopaedic Surgery & Traumatology ·Bora Uysal,Murat Beyzadeoğlu,Ömer Sağer,Selçuk Demiral,Hakan Gamsız,Ferrat Dinçoğlan,Mustafa Akın,Bahar Dırıcan	2014	9
13	Evaluation of Treatment Outcomes of Early-Stage Endometrial Cancer Radiotherapy: A Single Center Experience Asian Pacific Journal of Cancer Prevention ·Selçuk Demiral,Murat Beyzadeoğlu,Ömer Sağer,Ferrat Dinçoğlan,Bora Uysal,Hakan Gamsız,Mustafa Akın,Brett E. Bishop,Bahar Dırıcan	2014	4
14	Radiotherapy for Perianal Extramammary Paget's Disease: A case report Selçuk Demiral,Ömer Sağer,Ferrat Dinçoğlan,Bora Uysal,Hakan Gamsız,Serdar Sürenkök,Kaan Oysul,Sezai Demırbaş,Murat Demiriz,Murat Beyzadeoğlu	2013	0
15	Evaluation of linear accelerator-based stereotactic radiosurgery in the management of meningiomas: a single center experience. PubMed ·Ferrat Dinçoğlan,Murat Beyzadeoğlu,Ömer Sağer,Bora Uysal,Selçuk Demiral,Hakan Gamsız,Bahar Dırıcan	2013	54
16	Dosimetric evaluation of critical organs at risk in mastectomized left-sided breast cancer radiotherapy using breath-hold technique. PubMed ·Ferrat Dinçoğlan,Murat Beyzadeoğlu,Ömer Sağer,Kaan Oysul,HERBERT WITHINGTON,Hakan Gamsız,Bora Uysal,Selçuk Demiral,Bahar Dırıcan,Serdar Sürenkök	2013	21
17	Evaluation of stereotactic body radiotherapy (sbrt) boost in the management of endometrial cancer Neoplasma ·Selçuk Demiral,Murat Beyzadeoğlu,Bora Uysal,Kaan Oysul,Fan Zhong-feng,Ömer Sağer,Ferrat Dinçoğlan,Hakan Gamsız,Bahar Dırıcan,Serdar Sürenkök	2013	56
18	Dosimetric Evaluation of Intensity Modulated Radiotherapy and 4-Field 3-D Conformal Radiotherapy in Prostate Cancer Treatment Balkan Medical Journal ·Bora Uysal,Murat Beyzadeoğlu,Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Hakan Gamsız,Serdar Sürenkök,Kaan Oysul	2012	19
19	A Concise Review of High Dose Rate (HDR) Brachytherapy (BT) Boost as part of Breast Conserving Treatment (BCT) for Breast Cancer (BC) Ömer Sağer,Murat Beyzadeoğlu,Ferrat Dinçoğlan,Selçuk Demiral,Bora Uysal,Hakan Gamsız	2005	1
20	RADIOSURGERY TREATMENT VOLUME DETERMINATION FOR BRAIN LYMPHOMAS WITH AND WITHOUT INCORPORATION OF MULTIMODALITY IMAGING Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Murat Beyzadeoğlu	2005	32

About Ömer Sağer

Ömer Sağer is a scholar working on Genetics, Radiation, Pulmonary and Respiratory Medicine, Neurology and Epidemiology, having authored 109 papers that have together received 2.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (30 papers), Advanced Radiotherapy Techniques (24 papers), Brain Metastases and Treatment (23 papers), Meningioma and schwannoma management (22 papers), Vascular Malformations Diagnosis and Treatment (12 papers), Lung Cancer Diagnosis and Treatment (11 papers), Medical Imaging Techniques and Applications (8 papers) and Breast Cancer Treatment Studies (8 papers). The work is most often cited by research in Genetics (813 citations), Otorhinolaryngology (301 citations), Radiation (311 citations), Neurology (498 citations) and Pulmonary and Respiratory Medicine (892 citations). Ömer Sağer has collaborated with scholars based in Türkiye, Antigua and Barbuda and Somalia. Frequent co-authors include Murat Beyzadeoğlu, Ferrat Dinçoğlan, Selçuk Demiral, Bahar Dırıcan, Hakan Gamsız, Bora Uysal, Kaan Oysul, Sait Şirin, Serdar Sürenkök and Fatih Özcan. Their work appears in journals such as World Journal of Clinical Oncology, Tumori Journal, Electroencephalography and Clinical Neurophysiology, Concepts in Magnetic Resonance Part A and European Journal of Orthopaedic Surgery & Traumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact